Lee Jooyoung, Chung Su Jin, Choi Ji Min, Han Yoo Min, Kim Joo Sung
Department of Internal Medicine and Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
Department of International Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Gastroenterol Res Pract. 2020 Oct 22;2020:4028136. doi: 10.1155/2020/4028136. eCollection 2020.
This study was conducted on asymptomatic healthy individuals who underwent upper gastrointestinal endoscopy for the purpose of GC screening. Patients who were diagnosed with GC between October 2003 and December 2013 at Seoul National University Hospital Healthcare System Gangnam Center were identified. Demographic and clinicopathologic characteristics were compared between the groups with and without FHx of GC. Overall survival (OS) and recurrence-free survival (RFS) were assessed as primary outcomes.
There were no significant differences in tumor characteristics according to FHx of GC. However, preexisting adenoma was more frequent in patients with FHx than in those without FHx (14.5% vs. 6.3%, = 0.035). The proportion of patients with microsatellite instability (MSI) was also higher in groups with FHx of GC (43.2% vs. 13.2%, = 0.006). infection rates of patients with FHx of GC tended to be higher although not significant (70.5% vs. 61.3%, = 0.188). However, OS and RFS at 5 years of the GC patients with FHx were not significantly different from those of patients without FHx.
Preexisting adenoma and GC with MSI are more common in patients with FHx of GC than in those without. There were no significant differences in the survival rate according to FHx.
本研究针对因胃癌筛查目的而接受上消化道内镜检查的无症状健康个体开展。确定了2003年10月至2013年12月期间在首尔国立大学医院江南医疗中心被诊断为胃癌的患者。比较了有和没有胃癌家族史的两组患者的人口统计学和临床病理特征。将总生存期(OS)和无复发生存期(RFS)作为主要结局进行评估。
根据胃癌家族史,肿瘤特征无显著差异。然而,有胃癌家族史的患者中既往存在腺瘤的情况比无家族史的患者更常见(14.5%对6.3%,P = 0.035)。胃癌家族史组中微卫星不稳定性(MSI)患者的比例也更高(43.2%对13.2%,P = 0.006)。有胃癌家族史患者的感染率虽无显著差异但有升高趋势(70.5%对61.3%,P = 0.188)。然而,有胃癌家族史的胃癌患者5年的总生存期和无复发生存期与无家族史的患者无显著差异。
既往存在腺瘤和MSI型胃癌在有胃癌家族史的患者中比无家族史的患者更常见。根据家族史,生存率无显著差异。